Clements A - Search Results

1

Evidence for therapeutic drug monitoring of targeted anticancer therapies.

Gao B, Yeap S, Clements A, Balakrishnar B, Wong M, Gurney H. Gao B, et al. Among authors: clements a. J Clin Oncol. 2012 Nov 10;30(32):4017-25. doi: 10.1200/JCO.2012.43.5362. Epub 2012 Aug 27. J Clin Oncol. 2012. PMID: 22927532 Review.

2

Metformin in prostate cancer: two for the price of one.

Clements A, Gao B, Yeap SHO, Wong MKY, Ali SS, Gurney H. Clements A, et al. Ann Oncol. 2011 Dec;22(12):2556-2560. doi: 10.1093/annonc/mdr037. Epub 2011 Mar 18. Ann Oncol. 2011. PMID: 21421541 Free article. Review.

3

Facial palsy as a side effect of vemurafenib treatment in patients with metastatic melanoma.

Klein O, Ribas A, Chmielowski B, Walker G, Clements A, Long GV, Kefford RF. Klein O, et al. Among authors: clements a. J Clin Oncol. 2013 Apr 20;31(12):e215-7. doi: 10.1200/JCO.2012.45.7028. Epub 2013 Mar 18. J Clin Oncol. 2013. PMID: 23509307 No abstract available.

4

Acute Radiation Skin Toxicity Associated With BRAF Inhibitors.

Pulvirenti T, Hong A, Clements A, Forstner D, Suchowersky A, Guminski A, McNeil C, Hersey P, Fogarty G, Kefford R, Long GV, Wang W. Pulvirenti T, et al. Among authors: clements a. J Clin Oncol. 2016 Jan 20;34(3):e17-20. doi: 10.1200/JCO.2013.49.0565. Epub 2014 May 27. J Clin Oncol. 2016. PMID: 24868021 No abstract available.

5

Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma.

Chan MM, Kefford RF, Carlino M, Clements A, Manolios N. Chan MM, et al. Among authors: clements a. J Immunother. 2015 Jan;38(1):37-9. doi: 10.1097/CJI.0000000000000060. J Immunother. 2015. PMID: 25415286

6

Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks.

Anforth R, Carlos G, Clements A, Kefford R, Fernandez-Peñas P. Anforth R, et al. Among authors: clements a. Br J Dermatol. 2015 Jan;172(1):239-43. doi: 10.1111/bjd.13200. Epub 2014 Nov 21. Br J Dermatol. 2015. PMID: 25040674 Clinical Trial.

7

Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma.

Lee JHJ, Lyle M, Menzies AM, Chan MMK, Lo S, Clements A, Carlino MS, Kefford RF, Long GV. Lee JHJ, et al. Among authors: clements a. Pigment Cell Melanoma Res. 2018 May;31(3):404-410. doi: 10.1111/pcmr.12675. Epub 2017 Dec 7. Pigment Cell Melanoma Res. 2018. PMID: 29171176 Clinical Trial.

8

Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.

Lam T, Chan MM, Sweeting AN, De Sousa SM, Clements A, Carlino MS, Long GV, Tonks K, Chua E, Kefford RF, Chipps DR. Lam T, et al. Among authors: clements a. Intern Med J. 2015 Oct;45(10):1066-73. doi: 10.1111/imj.12819. Intern Med J. 2015. PMID: 26010858

9

A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab.

Carlos G, Anforth R, Chou S, Clements A, Fernandez-Peñas P. Carlos G, et al. Among authors: clements a. Melanoma Res. 2015 Jun;25(3):265-8. doi: 10.1097/CMR.0000000000000155. Melanoma Res. 2015. PMID: 25831416

10

Tinea hidden by a vemurafenib-induced phototoxic reaction in a patient with metastatic melanoma taking dexamethasone.

Anforth R, Carlos G, Eiris N, Clements A, Fernandez-Peñas P. Anforth R, et al. Among authors: clements a. Med J Aust. 2015 Jul 6;203(1):41-2. doi: 10.5694/mja14.00848. Med J Aust. 2015. PMID: 26126567 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

664 results

Search Page

Filters